Latest Dilution News

MaxiPARTS Limited has announced a fully franked ordinary dividend of AUD 0.0415 per share for the half-year ending December 2025, alongside a confirmed dividend reinvestment plan price of AUD 1.94 per share.

Percheron Therapeutics has announced a $2.2 million non-renounceable entitlement offer at a 20% discount, including free options, to fund the next phase of its lead oncology asset HMBD-002.

Cann Group Limited has raised $750,000 through a convertible note agreement with Obsidian Global, aiming to strengthen its working capital and move towards EBITDA positivity.

Lithium Energy Limited has revealed a detailed two-year, $36 million plan to advance its battery minerals projects, supported by a robust $68 million cash position as it prepares for ASX relisting.

Tetratherix Limited launches a new precision medicine franchise leveraging its Tetramatrix™ platform, securing a decade-long exclusive partnership with US health group Superpower Health Inc. This deal promises immediate revenue and complements ongoing FDA milestones.

Argo Investments Limited has confirmed a fully franked dividend of AUD 0.185 per share for the half-year ending December 2025, alongside updated details on its Dividend Reinvestment Plan and Bonus Security Plan pricing.

Excite Technology Services has secured $1.05 million through convertible notes, aiming to capitalise on its strongest operational cash flow quarter and accelerate growth.

Everest Metals Corporation reports outstanding high-grade gold intersections from its latest drilling at Mt Dimer Taipan, underpinning imminent mining and processing milestones. The project is fully funded and on track for near-term cash flow.

Count Limited has declared a fully franked interim dividend of 2.00 cents per share for 1HFY26, with a Dividend Reinvestment Plan allocation price fixed at $1.08. The company will issue over 650,000 new shares to participating shareholders.

Imugene Limited has launched a $20 million capital raising through a $12 million institutional placement and an $8 million Share Purchase Plan, alongside a convertible notes amendment to support its clinical development pipeline.

Evolution Energy Minerals has successfully closed an oversubscribed $4 million rights issue, supplemented by a $150,000 follow-on placement, bolstering funds for key exploration and development projects.

ActivEX Limited has secured $421,753 through a placement of over 21 million shares at a slight discount, locking in investors for 12 months. The funds aim to boost exploration projects and shore up working capital.